We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
-20.71%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$584M
AUM Growth
-$155M
Cap. Flow
+$14.2M
Cap. Flow %
2.42%
Top 10 Hldgs %
99.8%
Holding
12
New
2
Increased
1
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
TECX
Tectonic Therapeutic
TECX
+$15.6M
2
NCNA
NuCana
NCNA
+$4.4M
3
PRTA icon
Prothena Corp
PRTA
+$888K

Top Sells

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$4.23M
2
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$1.58M
3
CLRB icon
Cellectar Biosciences
CLRB
+$967K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$366M 62.68%
14,075,269
– –
HRTX icon
2
Heron Therapeutics
HRTX
$86.3M
$102M 17.45%
5,514,096
-230,000
-4% -$4.23M
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
$43.5M 7.44%
4,938,893
– –
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$348M
$34.5M 5.91%
2,965,485
– –
TECX
5
Tectonic Therapeutic
TECX
$573M
$11.7M 2%
+69,093
New +$15.6M
CELG
6
DELISTED
Celgene Corp
CELG
$11.1M 1.9%
111,844
– –
PBYI icon
7
Puma Biotechnology
PBYI
$406M
$3.76M 0.64%
349,400
– –
NCNA
8
NuCana
NCNA
$5.37M
$3.62M 0.62%
+100
New +$4.4M
GTHX
9
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3.42M 0.58%
150,000
-50,000
-25% -$1.58M
PRTA icon
10
Prothena Corp
PRTA
$458M
$3.32M 0.57%
423,823
+100,000
+31% +$888K
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$672K 0.12%
600,000
– –
CLRB icon
12
Cellectar Biosciences
CLRB
$19.3M
$471K 0.08%
786
-1,481
-65% -$967K

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $1.96B AUM 43.61% 1-Year Est. Return
CCA
Checchi Capital Advisers Beverly Hills, California $1.98B AUM 19.17% 1-Year Est. Return
FWTB
First Western Trust Bank Denver, Colorado $1.98B AUM 1.62% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return

Tang Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Tang Capital Management held 12 positions worth $584M, down 21% from $740M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management's Q3 2019 filing shows 2 new, 1 increased and 3 reduced positions. Its largest new stake was Tectonic Therapeutic: 69,093 shares worth $11.7M. The largest sale was Heron Therapeutics, an estimated $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tang Capital Management's largest Q3 2019 buy was Tectonic Therapeutic: 69,093 shares worth $11.7M.
  • Tang Capital Management added most to Prothena Corp in Q3 2019, an estimated $888K increase.
  • Tang Capital Management's biggest Q3 2019 reduction was Heron Therapeutics, cutting an estimated $4.23M.
  • Tang Capital Management's ten largest holdings make up 100% of its $584M portfolio in Q3 2019.
  • Tang Capital Management opened 2 new positions and closed 0 in Q3 2019.
  • Tang Capital Management's portfolio value fell 21% quarter-over-quarter to $584M.

Based on Tang Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.